Tuesday, May 04, 2021 5:33:39 PM
About Sonnet BioTherapeutics Holdings, Inc.
Founded in 2011, Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating
biologic drugs of single or bispecific action.
Known as FHAB (Fully Human Albumin Binding),
the technology utilizes a fully human single chain antibody fragment
(scFv)
that binds to and "hitch-hikes" on human serum albumin (HSA) for transport to target tissues.
Sonnet's FHAB was designed to specifically target tumor and lymphatic tissue,
with an improved therapeutic window for optimizing the safety
and efficacy of immune modulating biologic drugs.
FHAB is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes,
including cytokines, peptides, antibodies and vaccines.
Recent SONN News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:30:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 12:35:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 12:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:20:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 09:15:16 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/05/2024 05:15:16 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/02/2024 09:19:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:56:04 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/22/2023 09:31:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 10:03:39 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/14/2023 10:02:10 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 11/17/2023 04:32:52 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 11/06/2023 04:35:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/28/2023 12:00:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/28/2023 12:00:08 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 10/26/2023 01:00:19 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/19/2023 09:14:13 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/04/2023 08:18:01 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/28/2023 12:48:54 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/19/2023 08:30:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 12:30:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 12:30:33 PM
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM